A Phase 2a placebo-controlled, randomised, proof of concept trial to investigate the feasibility, safety, and efficacy of psilocybin therapy in opioid use disorder (OUD).
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.